Trials / Unknown
UnknownNCT04280263
Caffeine Study for Pain Control Following Total Joint Replacement
A Prospective Double Blinded Randomized Placebo Controlled Study of the Efficacy of Caffeine as an Analgesic Adjuvant for Acute Perioperative Pain Management Following Total Joint Arthroplasty
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Rothman Institute Orthopaedics · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, double blinded, single center, randomized controlled study to evaluate the efficacy of caffeine in combination with acetyl salicylic acid (ASA) in the management of postoperative pain in patients undergoing total joint arthroplasty.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Caffeine | caffeine tables containing 150mg caffeine will be provided to patients with instructions to take twice per day |
| DRUG | Placebo oral tablet | oral placebo tablets matching the caffeine tablets and will be provided to patients with instructions to take twice per day |
Timeline
- Start date
- 2020-02-28
- Primary completion
- 2021-06-01
- Completion
- 2021-08-01
- First posted
- 2020-02-21
- Last updated
- 2020-10-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04280263. Inclusion in this directory is not an endorsement.